These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27229901)

  • 1. Nanoparticles and direct immunosuppression.
    Ngobili TA; Daniele MA
    Exp Biol Med (Maywood); 2016 May; 241(10):1064-73. PubMed ID: 27229901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.
    Ilinskaya AN; Dobrovolskaia MA
    Br J Pharmacol; 2014 Sep; 171(17):3988-4000. PubMed ID: 24724793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction.
    Gharagozloo M; Majewski S; Foldvari M
    Nanomedicine; 2015 May; 11(4):1003-18. PubMed ID: 25596076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus.
    Look M; Saltzman WM; Craft J; Fahmy TM
    Biomaterials; 2014 Jan; 35(3):1089-95. PubMed ID: 24183697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview on experimental models of interactions between nanoparticles and the immune system.
    Najafi-Hajivar S; Zakeri-Milani P; Mohammadi H; Niazi M; Soleymani-Goloujeh M; Baradaran B; Valizadeh H
    Biomed Pharmacother; 2016 Oct; 83():1365-1378. PubMed ID: 27580456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for Analysis of Nanoparticle Immunosuppressive Properties.
    Cedrone E; Potter TM; Neun BW; Dobrovolskaia MA
    Methods Mol Biol; 2024; 2789():217-228. PubMed ID: 38507007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles and the immune system.
    Zolnik BS; González-Fernández A; Sadrieh N; Dobrovolskaia MA
    Endocrinology; 2010 Feb; 151(2):458-65. PubMed ID: 20016026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A framework for designing delivery systems.
    Poon W; Kingston BR; Ouyang B; Ngo W; Chan WCW
    Nat Nanotechnol; 2020 Oct; 15(10):819-829. PubMed ID: 32895522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
    Rodríguez-Perálvarez M; Guerrero-Misas M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011639. PubMed ID: 28362060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery.
    Smith SA; Selby LI; Johnston APR; Such GK
    Bioconjug Chem; 2019 Feb; 30(2):263-272. PubMed ID: 30452233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases.
    Li Y; Lou Y; Chen Y; Yang J; Li D; Jiang B; Lan J; Wen J; Fu Y; Zhang Y; Tao J; Zhu J
    Theranostics; 2021; 11(8):3694-3709. PubMed ID: 33664856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective delivery of mycophenolic acid by oxygen nanobubbles for modulating immunosuppression.
    Khan MS; Kim JS; Hwang J; Choi Y; Lee K; Kwon Y; Jang J; Yoon S; Yang CS; Choi J
    Theranostics; 2020; 10(9):3892-3904. PubMed ID: 32226527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional and Novel Approaches to Immunosuppression in Lung Transplantation.
    Patterson CM; Jolly EC; Burrows F; Ronan NJ; Lyster H
    Clin Chest Med; 2023 Mar; 44(1):121-136. PubMed ID: 36774159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways.
    Li Z; Zhang Y; Zhu D; Li S; Yu X; Zhao Y; Ouyang X; Xie Z; Li L
    Drug Deliv; 2017 Dec; 24(sup1):45-55. PubMed ID: 29069996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation.
    Zwart TC; Guchelaar HJ; van der Boog PJM; Swen JJ; van Gelder T; de Fijter JW; Moes DJAR
    Drug Discov Today; 2021 Nov; 26(11):2527-2546. PubMed ID: 34119665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs.
    Parlakpinar H; Gunata M
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):651-665. PubMed ID: 34415233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of Immunological Tolerance as a Therapeutic Procedure.
    Waldmann H; Howie D; Cobbold S
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New immunosuppressive agents in pediatric transplantation.
    Nguyen C; Shapiro R
    Clinics (Sao Paulo); 2014; 69 Suppl 1(Suppl 1):8-16. PubMed ID: 24860853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.